Atlas Discovery GTM brain

Atlas Discovery uses AI agents to search biomedical knowledge for rare disease treatment hypotheses, working with disease foundations and research partners.

category

AI rare disease drug discovery

market profile

  • text: Rare diseases often lack approved treatments and conventional development economics can leave small populations underserved.
  • text: Biomedical literature and disease-to-drug connections are too extensive for manual review alone.

personas

  • title: Rare disease foundation research director
    pains:
    • Patients lack approved treatments while research budgets are limited.
    • A small team cannot systematically assess the full biomedical literature for repurposing leads.
  • title: Biotech translational research lead
    pains:
    • Connecting disease mechanisms to testable drug hypotheses requires fragmented evidence.
    • Computational predictions require experimental and clinical validation before treatment decisions.

icp

  • text: Rare disease foundations with a defined indication and access to research or testing partners are evidenced early collaborators.
  • text: Biotech and academic translational teams evaluating repurposing hypotheses are plausible partners; size and purchasing terms are not public.

message pillars

  • text: Find overlooked treatment possibilities for rare diseases.
  • text: Use agents to search an otherwise unmanageable knowledge base.
  • text: Make the company's identity clear as a drug developer.

objections

  • objection: Is a predicted drug a proven treatment?
    response: No. Treat surfaced drugs as hypotheses requiring appropriate independent experimental and clinical evaluation.
  • objection: How can a small patient population support development?
    response: Discuss the economics and a specific partnership plan; Atlas targets diseases neglected by conventional development economics.

competitors

  • name: Healx
    website: https://healx.ai/rta/
    why: AI-enabled rare disease biotech pursuing drug redevelopment partnerships.
  • name: Every Cure
    website: https://everycure.org/portfolio/
    why: Nonprofit alternative using AI to identify and advance drug repurposing opportunities.

keywords

  • rare disease drug discovery
  • AI drug repurposing
  • rare disease treatment research
  • biomedical knowledge graph
  • orphan drug discovery
  • drug disease hypothesis generation

voice

  • Mission-driven
  • Scientific and concise
  • Ambitious

signals

  • text: A rare disease foundation funds translational research or seeks drug repurposing partners.
  • text: A research group has a defined underserved disease and capacity to validate candidate drugs.

pricing

model: unknown

motion

unknown

channels

  • Research publications
  • Partnerships
  • LinkedIn
  • X

confidence

medium

Founders

  • name: Shaamil Karim
    title: Founder/CEO
    role: CEO
    bio: Excited about AI for predictive biology
  • name: Christian Gensbigler
    title: Founder
    role: Founder
    bio: Previously MTS at Origin Bio (YC w26), theoretical biology at Johns Hopkins School of Medicine, math at Dartmouth

Back to YC companies